Novorapid



Indications and Reactions:

Role Indications Reactions
Primary
Type 1 Diabetes Mellitus 32.1%
Type 2 Diabetes Mellitus 12.7%
Drug Use For Unknown Indication 11.3%
Product Used For Unknown Indication 10.7%
Diabetes Mellitus 8.6%
Insulin-requiring Type 2 Diabetes Mellitus 5.8%
Insulin-requiring Type Ii Diabetes Mellitus 4.3%
Gestational Diabetes 3.1%
Diabetes Mellitus Insulin-dependent 2.7%
Hypertension 2.1%
Hypothyroidism 1.2%
Anaemia 1.1%
Asthma 1.0%
Adrenal Insufficiency 0.5%
Diabetes Insipidus 0.5%
Heart Disease Congenital 0.5%
Pain 0.5%
Prophylaxis 0.5%
Chronic Obstructive Pulmonary Disease 0.4%
Hyperglycaemia 0.4%
Hypoglycaemia 12.3%
Premature Baby 12.3%
Drug Exposure During Pregnancy 9.1%
Suicide Attempt 7.1%
Loss Of Consciousness 6.5%
Vomiting 5.8%
Myocardial Infarction 5.2%
Pregnancy 4.5%
Death 3.9%
Hepatic Steatosis 3.9%
Pseudomonas Infection 3.9%
Diabetes Mellitus Inadequate Control 3.2%
Injection Site Rash 3.2%
Insulin Resistance 3.2%
Insulin Resistance Syndrome 2.6%
Medication Error 2.6%
Premature Rupture Of Membranes 2.6%
Pyrexia 2.6%
Weight Decreased 2.6%
Wrong Drug Administered 2.6%
Secondary
Type 2 Diabetes Mellitus 21.7%
Product Used For Unknown Indication 16.8%
Diabetes Mellitus 16.1%
Type 1 Diabetes Mellitus 14.6%
Drug Use For Unknown Indication 5.2%
Hypertension 3.4%
Prophylaxis 3.1%
Diabetes Mellitus Insulin-dependent 2.6%
Gestational Diabetes 2.4%
Drug Exposure During Pregnancy 2.2%
Thrombosis Prophylaxis 2.1%
Peripheral Arterial Occlusive Disease 1.9%
Cardiac Failure 1.3%
Diabetic Neuropathy 1.1%
Reflux Oesophagitis 1.1%
Cataract 1.0%
Prophylaxis Against Diarrhoea 1.0%
Diabetes Mellitus Inadequate Control 0.8%
Suicide Attempt 0.8%
Pain 0.7%
Hypoglycaemia 24.0%
Premature Baby 8.7%
Weight Decreased 5.5%
Hypoglycaemic Coma 5.1%
Hyperglycaemia 4.7%
Pre-eclampsia 4.7%
Death 4.4%
Diabetes Mellitus Inadequate Control 4.4%
Pregnancy 4.4%
Renal Failure Acute 4.4%
Drug Exposure During Pregnancy 4.0%
Loss Of Consciousness 4.0%
Vomiting 3.3%
Tachycardia 2.9%
Transient Tachypnoea Of The Newborn 2.9%
Foetal Distress Syndrome 2.5%
Hepatic Function Abnormal 2.5%
Hypertension 2.5%
Hypoglycaemic Unconsciousness 2.5%
Hypothermia 2.5%
Concomitant
Product Used For Unknown Indication 23.1%
Diabetes Mellitus 16.6%
Hypertension 13.6%
Drug Use For Unknown Indication 11.1%
Type 2 Diabetes Mellitus 7.1%
Type 1 Diabetes Mellitus 4.6%
Prophylaxis 3.4%
Pain 2.8%
Rheumatoid Arthritis 2.4%
Hyperlipidaemia 1.8%
Hepatitis C 1.8%
Constipation 1.6%
Hiv Infection 1.5%
Depression 1.4%
Diabetic Neuropathy 1.3%
Cardiac Failure 1.3%
Insomnia 1.3%
Hypothyroidism 1.2%
Diabetes Mellitus Insulin-dependent 1.2%
Renal Transplant 1.0%
Vomiting 13.2%
Hypoglycaemia 9.8%
Renal Failure Acute 8.1%
Weight Increased 6.2%
Weight Decreased 5.9%
Pyrexia 5.4%
Interstitial Lung Disease 5.3%
Renal Impairment 4.7%
Pneumonia 4.5%
White Blood Cell Count Decreased 4.5%
Sepsis 4.1%
Renal Failure 3.6%
Hepatic Function Abnormal 3.5%
Tremor 3.2%
Hyperglycaemia 3.1%
Somnolence 3.1%
Nausea 3.0%
Transplant Rejection 3.0%
White Blood Cell Count Increased 3.0%
Blood Glucose Increased 2.9%
Interacting
Diabetes Mellitus 22.0%
Drug Use For Unknown Indication 22.0%
Hypertension 11.0%
Anxiety 6.0%
Intentional Overdose 6.0%
Parkinson's Disease 6.0%
Suicide Attempt 6.0%
Cardiac Failure Chronic 3.0%
Cerebral Infarction 3.0%
Prophylaxis Against Gastrointestinal Ulcer 3.0%
Bronchopulmonary Aspergillosis Allergic 2.0%
Essential Hypertension 2.0%
Peripheral Arterial Occlusive Disease 2.0%
Restlessness 2.0%
Back Pain 1.0%
Depression 1.0%
Ischaemic Heart Disease Prophylaxis 1.0%
Neuralgia 1.0%
Suicide Attempt 35.3%
Hypoglycaemia 17.6%
Surgery 17.6%
Tachycardia 11.8%
Hyperglycaemia 5.9%
Sleep-related Eating Disorder 5.9%
Transient Ischaemic Attack 5.9%